David G. Hill MD FCCP
Asthma & COPD, Critical Care Medicine, Pleural Disease
Partner and Director Clinical Research at Waterbury Pulmonary Associates
Join to View Full Profile
170 Grandview AveWaterbury, CT 06708
Phone+1 203-759-3666
Fax+1 203-759-3671
Dr. Hill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Hill is a pulmonologist based in Waterbury, CT, specializing in asthma, COPD, and critical care medicine. He completed his medical education at MCP-Hahnemann College of Medicine and undertook his residency at the University of Connecticut, followed by a fellowship in Pulmonary Disease and Critical Care Medicine at Yale-New Haven Medical Center. Dr. Hill is experienced in managing conditions such as asthma, chronic obstructive pulmonary disease, and venous thromboembolism, with a background in biomedical research. He has authored multiple publications, including research on lung cancer detection and COPD therapy. His work has been recognized with several CMS Meaningful Use Stage certifications and he has been named a Top MD by Consumers' Checkbook. Dr Hill is a long term volunteer for the American Lung Association and currently serves as the Chairperson of their National Board of Directors.
Education & Training
Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1997
University of ConnecticutResidency, Internal Medicine, 1991 - 1994
MCP-Hahnemann College of MedicineClass of 1991
Certifications & Licensure
CT State Medical License 1993 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MediTouch EHR, HealthFusion, 2014-2017
- CMS Meaningful Use Stage 2 Certification MediTouch, HealthFusion, 2014-2017
- CMS Meaningful Use Stage 1 Certification MediTouch, HealthFusion, 2014-2017
Publications & Presentations
PubMed
- 1 citationsDecision in Braidwood v. Becerra increases uncertainty in coverage for cancer screenings.David G Hill, Ernest Hawk
Cancer. 2025-01-15 - 12 citationsDetection of early-stage lung cancer in sputum using automated flow cytometry and machine learning.Madeleine E Lemieux, Xavier T Reveles, Jennifer Rebeles, Lydia H Bederka, Patricia R Araujo
Respiratory Research. 2023-01-21 - 6 citationsSingle-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.Samuel Bardsley, Gerard J Criner, David M G Halpin, MeiLan K Han, Nicola A Hanania
Respiratory Medicine. 2022-12-01
Press Mentions
Officials Urge Precautions and Vaccinations as Flu, RSV Cases RiseDecember 9th, 2025- American Lung Association Launches Campaign to Encourage VaccinationsOctober 13th, 2025
- CT Doctors, Officials Warn EPA Rollback Threatens Air Quality and Public Health: 'At Greater Risk'August 24th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
